Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Learning Healthcare System for the Prescription of Genetic Testing in the Gynecological Cancer Risk.

Studies in health technology and informatics - 1 Jan 2017

Suárez-Mejías Cristina, Martínez-García Alicia, Martínez-Maestre María Ángeles, Silvan-Alfaro José Manuel, Moreno Conde Jesús, Parra-Calderón Carlos Luis

Abstract excerpt

Clinical evidence demonstrates that BRCA 1 and BRCA2 mutations can develop a gynecological cancer but genetic testing has a high cost to the healthcare system. Besides, several studies in the literature indicate that performing these genetic tests to the population is not cost-efficient. Currently, our physicians do not have a system to provide them the support for prescribing genetic tests. A Decision Support...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Decision Support Systems, Clinical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Genital Neoplasms, Female

Share to Risk Factors

Source

Identifiers

PMID: 28423763

Genes

BRCA2
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Learning Healthcare System for the Prescription of Genetic Testing in the Gynecological Cancer Risk.PMID 28423763Read ↗

ChatGPT accurately performs genetic counseling for gynecologic cancersSemantic proximity Read ↗

Knowledge and Attitudes of Personalized Medicine, Genetic Testing, and Health Data Sharing: A Comprehensive Survey in the general public of the European UnionSemantic proximity Read ↗

Are we ready for online tools in decision making for BRCA1/2 mutation carriers?Semantic proximity Read ↗

Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical PracticeSemantic proximity Read ↗

Improving Genetic Knowledge Among Physicians: A Necessity in the Era of Genomic MedicineSemantic proximity Read ↗

Development, Implementation and Initial Results of CDSS Recommendations for Patients at Risk of Hereditary Breast Cancer.Semantic proximity Read ↗

Technical desiderata for the integration of genomic data with clinical decision supportSemantic proximity Read ↗

BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic.Semantic proximity Read ↗

Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancerSemantic proximity Read ↗

Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer.Semantic proximity Read ↗

Cancer Risk Prediction Regulation Models: Canada Contrasted with the U.S. and the E.U.Semantic proximity Read ↗

Artificial Intelligence for Genetic Cancer Risk Assessment in Gynecologic Oncology: A Review of the Current Landscape and Future Directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.